Emsita Trio 10mg/500mg/100mg Tablet ER is a combination medication containing Dapagliflozin, Metformin, and Sitagliptin used to help manage blood glucose levels in individuals with diabetes. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose, allowing it to be eliminated through urine. Metformin helps reduce the production of glucose in the liver and improves the body’s response to insulin. Sitagliptin works by increasing the levels of incretin hormones that help regulate insulin release after meals. The combined action of these medicines helps maintain stable blood sugar levels and improves overall glycemic control. The extended release formulation allows the medicine to release gradually in the body, providing long lasting effectiveness throughout the day. Maintaining controlled blood sugar levels is important for reducing the risk of diabetes related complications. When used as directed by a healthcare professional along with healthy lifestyle practices, Emsita Trio Tablet ER helps support effective diabetes management and overall metabolic health.